What's New
Check out the latest from the newsroom
The GARFIELD-AF tool allows a single calculation for mortality, stroke and bleeding and can assist in risk/benefit decision-making.
The GARFIELD-AF(G...
An 88 yo patient who is fully independent, is brought into ED by ambulance in Cardiogenic Shock. The only past history the patient has is hypertension...
In this podcast we go on the patient journey, of a 61 yo patient who presents at 11pm at night with an irregularly irregular pulse, at a rate of 167 b...
When I cardiovert AF, I use the highest energy possible energy inĀ the first cardioversion attempt. I consider this to be aĀ resistant arrhythmia and wa...
When cardioverting patients in new atrial fibrillation, we want our first attempt to be our best attempt.Ā
The EPIC Trial(1) (Electrode Position In...
Atrial Fibrillation is the most common arrhythmia we see. Conversion to sinus rhythm of recent-onset of atrial fibrillation isĀ proven to be safe. Ho...
Ā
Here we review the RACE7 ACWAS (Rate Control vs Cardioversion Trial7-Acute Cardioversion versus Wait and See) Trial (1).
Ā
What they did
This wa...
Does a normal ECG exclude Hyperkalaemia?
Do we treat patients with a K+ < 6.5 mmol/L?
Do ECG changes in hyperkalaemia predict a adverse outcome?
Should w...
Patients with subclinical atrial fibrillation, detected by implantable devices, have an increased stroke risk, although not as great as that of patien...